IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Statins and Risk of Myocardial Infarction in Real Life in France
This study has been completed.
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00679575
First received: May 15, 2008
Last updated: December 6, 2010
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The main objective of this case-referent study is to assess the impact of statins usage on the risk of having a first myocardial infarction (MI) in a real life situation in France
| Condition |
|---|
| Myocardial Infarction |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Statins and Risk of Myocardial Infarction in Real Life in France |
Resource links provided by NLM:
Further study details as provided by AstraZeneca:
Primary Outcome Measures:
- Assess the impact of the different statins (molecules) usage on the risk of having a first myocardial infarction in a real life situation in France [ Time Frame: in 2011 ]
Secondary Outcome Measures:
- Assess the interaction between statin treatment and risk factors such as cholesterol, age, gender, tobacco, alcohol, co-prescriptions, co-morbidities [ Time Frame: in 2011 ]
- Assess the populational impact of statins usage on the risk of having a first myocardial infarction [ Time Frame: in 2011 ]
- Assess the risk of having a first myocardial infarction according to high and low dosages of statins [ Time Frame: in 2011 ]
| Enrollment: | 13171 |
| Study Start Date: | March 2007 |
| Study Completion Date: | November 2010 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Cases : Patients with a first myocardial infarction
|
|
2
Referents : Patients recruited by a GP during a routine consultation
|
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Study Population
Cases : Patients recruited by a cardiologist in hospital / Referents : Patients recruited by a GP, community sample
Criteria
Inclusion Criteria:
- Patients can speak French or English
- Patients can be interviewed by telephone
- Place of usual residence in the area of recruitment
Exclusion Criteria:
- Patients refusing to participate in the study
- Patients who cannot be reached by telephone
- Previous history of myocardial infarction
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00679575
Hide Study Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00679575
Hide Study Locations
Locations
| France | |
| Research Site | |
| Ambilly, France | |
| Research Site | |
| Angers, France | |
| Research Site | |
| Arles, France | |
| Research Site | |
| Bagnols sur Ceze, France | |
| Research Site | |
| Bayonne, France | |
| Research Site | |
| Beziers, France | |
| Research Site | |
| Boulogne sur mer, France | |
| Research Site | |
| Bourgoin Jallieu, France | |
| Research Site | |
| Bron, France | |
| Research Site | |
| Cambo les Bains, France | |
| Research Site | |
| Cenon, France | |
| Research Site | |
| Chateauroux, France | |
| Research Site | |
| Clermont Ferrand, France | |
| Research Site | |
| Colmar, France | |
| Research Site | |
| Crest, France | |
| Research Site | |
| Dijon, France | |
| Research Site | |
| Draguignan, France | |
| Research Site | |
| Eaubonne, France | |
| Research Site | |
| Firminy, France | |
| Research Site | |
| Forbach, France | |
| Research Site | |
| Frejus, France | |
| Research Site | |
| Gleize, France | |
| Research Site | |
| Grasse, France | |
| Research Site | |
| Gueret, France | |
| Research Site | |
| La Rochelle, France | |
| Research Site | |
| Langres, France | |
| Research Site | |
| Laon, France | |
| Research Site | |
| Le Coudray, France | |
| Research Site | |
| Le Mans, France | |
| Research Site | |
| Le Puy en Velay, France | |
| Research Site | |
| Mayenne, France | |
| Research Site | |
| Millau, France | |
| Research Site | |
| Montelimar, France | |
| Research Site | |
| Montfermeil, France | |
| Research Site | |
| Montpellier, France | |
| Research Site | |
| Nimes, France | |
| Research Site | |
| Orange, France | |
| Research Site | |
| Orleans, France | |
| Research Site | |
| Paris, France | |
| Research Site | |
| Pau, France | |
| Research Site | |
| Perpignan, France | |
| Research Site | |
| Puilboreau, France | |
| Research Site | |
| Rueil Malmaison, France | |
| Research Site | |
| Rumilly, France | |
| Research Site | |
| Saint Jean des Verges, France | |
| Research Site | |
| Sallanches, France | |
| Research Site | |
| Salon de provence, France | |
| Research Site | |
| Sens, France | |
| Research Site | |
| St Amand Monrond, France | |
| Research Site | |
| St-Esteve, France | |
| Research Site | |
| Thonon les Bains, France | |
| Research Site | |
| Toulouse, France | |
| Research Site | |
| Tours, France | |
| Research Site | |
| Tulles, France | |
| Research Site | |
| Valence, France | |
| Research Site | |
| Villefranche de Rouergue, France | |
Sponsors and Collaborators
AstraZeneca
Investigators
| Study Chair: | Lucien Abenhaim | LA-SER29, rue du Faubourg Saint-Jacques75014 Paris |
More Information
| Responsible Party: | Russel Esterline, AstraZeneca |
| ClinicalTrials.gov Identifier: | NCT00679575 History of Changes |
| Other Study ID Numbers: |
NIS-CFR-CRE-2007/1 |
| Study First Received: | May 15, 2008 |
| Last Updated: | December 6, 2010 |
Keywords provided by AstraZeneca:
|
statins myocardial infarction case-referent study France |
Additional relevant MeSH terms:
|
Infarction Myocardial Infarction Ischemia Pathologic Processes Necrosis |
Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on September 21, 2017